Skip to main content

regular check-up, plus a bonus health insurance rant!

I was considering skipping this update because there’s nothing much new to report and I didn’t have that much to write. But it turns out I had a lot to say. This is why I tell my students that writing is a way of thinking: You don’t wait to write until you know what you think; you write to figure out what you think.

We had an uneventful 4-month check-up in Pittsburgh yesterday. Well, I did develop a UTI right before going to bed on Monday night, so that was eventful! (Why do such problems always pop up after all the clinics are closed?) I took over-the-counter meds -- thank goodness I had some on hand -- to get me through the night and the drive to Pittsburgh. Then my oncologist wrote a script for antibiotics, which we picked up when we returned to State College. I’ve discovered that UTIs are a common side effect of Tagrisso. I had one in my entire life pre-Tagrisso, and in the past 2.5 years, I've had at least 4 (a month of recurring UTIs in 2023, last September, and now). Fun times.

This visit also reminded me why I do not read the CT scan report before seeing my oncologist. She asked if I’d been sick recently, and I confirmed that I had a cold after Thanksgiving. She pointed to a new spot on the CT scan and mentioned that it was noted in the radiologist’s report. “A 7 mm nodular density within the superior segment of the right lower lobe on image 94 is new since prior exam.” Dr. Villaruz suspects this is leftover gunk from my cold. And this, my friends, is why I do not read the report beforehand! Reading about a new nodule would certainly have freaked me out – and for no reason.

My scans are stable, and I will return in 4 months. December 30 will mark 3.5 years on Tagrisso, my miracle medication!!

Every 1.5-2 years, I get a brain MRI. This was clear, although many questions remain about how my brain operates.

Finally, on January 1 PSU is switching from Accredo (which I hated because of their general incompetence and many errors) to CVS Caremark for “specialty” medications. For expensive medications like Tagrisso and Enoxparin (my blood thinner), you can’t just pick it up at your local pharmacy. It must go through a specialty pharmacy and is mailed. The switch is supposed to be a “seamless” process, yet I spent about 1.5 hours last week on routine phone calls with AstraZeneca (the company that makes Tagrisso), CVS Caremark, and PrudentRx (a company that can save $ on specialty medications) going over my basic information, medication names and dosages, etc.

Through this, I discovered that Accredo messed up yet again. They lost my blood thinner prescription in September or October, so I had called my hematologist for another prescription the following month. That newer prescription has now disappeared (I should still have refills remaining, but there are none). Only prescriptions with existing refills will transfer to CVS. Hence, in January I will have to call my hematologist again to ask for yet another new prescription.

Accredo also started charging me $50 for Tagrisso the last 2 months. Until now, it has been free because it’s covered by insurance, and the remaining $50 copay is covered by AstraZeneca’s Access 360 program. The AZ rep told me that my Access 360 account should automatically be covering that $50, but for some reason Accredo is still charging me. Accredo also randomly and inexplicably over-charged me by $90+ for my blood thinner, so I am fighting that. I have sent more emails to the PSU Highmark concierge who troubleshoots all these issues for me. We are also fighting a large bill of Leland's that insurance won't pay, plus a $500+ charge for Lily's (negative) mono test at Mt. Nittany months ago, something that cost a nominal amount at our private practice doctor in 2024. Our long-time doctor, Dr. McCleary, was driven out of business by Highmark's low reimbursement rates for private practice and started working at the VA Hospital in Harrisburg. We are still devastated. :(

Anyway, if the $50 Tagrisso co-pay will no longer be covered, then I will go from paying nothing for Tagrisso to paying $1200/year, because PSU decided to increase the cost for specialty medication co-pays from $50 to $100/month.* So there goes a big chunk of my small raise, which was just barely above increased cost of living. By contrast, President Bendapudi got a 50% raise of $450,000 plus all kinds of other monetary benefits.

*I and a few other members of the Faculty Benefits Committee have repeatedly pressed PSU to charge people who make $200K - $300K/year the same percentage of their income for healthcare premiums as everyone else. The answer is always a hard no, and the same reason is always given: “We have to remain competitive” in attracting employees (read: the highest-earning employees), and they might decide to work elsewhere if health insurance premiums are too high.

PSU pegs the premium to the health plan you choose and your salary (the less you earn, the less you pay), which I wholeheartedly support. These high earners (above $200K) pay a higher amount in absolute dollars, but as a percentage of their salary, it’s much lower. For instance, employees with our insurance plan and family coverage pay 5.51% of salary for monthly premiums. For someone making $75K, this is $344/month; if you earn $200K, it’s $918. Everyone who earns over $200K (including the new and former football coaches) also pays $918. For someone earning, say, $300K, that is only 3.06% of annual salary.

Penn State’s insurance costs are rising for many reasons (including federal government cuts to Medicaid and the cost of GLP-1 medications). However, I have long argued that making higher earners pay their fair share could help offset the costs for everyone else. Instead, those of us whose lives depend on specialty medications will have to pay more. Our family will almost certainly pay more on top of that because the out-of-pocket maximum is also increasing, as is the cost for going to the ER (from $100 to $200). We obviously try to avoid the ER, but last year I had to go twice because of my knee--another health crisis that happened when doctors’ offices and express clinics were closed. It is infuriating to hear some HR reps imply that people use the ER glibly rather than using less expensive options, and that the higher charge will make us think twice and make more financially responsible decisions.

So, all told, our family might end up paying thousands more dollars in healthcare in 2026. We have insurance and can afford the higher costs, but many families either don't have insurance or can't afford the increased costs.

Comments

  1. Well said ! I am glad you are stable :)

    ReplyDelete
  2. Thank you, Esther. I am glad that your report was not changed. But there are so many things I could say about the cost of living and administration pay. And yes, healthcare should be a right, not a privilege for those who can only afford it.

    ReplyDelete
    Replies
    1. Thank you, Leslie. The healthcare situation in our country is horrendous. :(

      Delete
  3. Thanks for the update. So many things that you wrote about resonated with me: how you think that you have nothing to write, only to start writing and realizing that you have something important to say; the unbelievable waste of time and energy that one can spend talking with insurance companies and pharmacies and/or medical office staff; how scary it can be to read the medical reports and think the worse, until your doctor explains; and how painful UTIs are, especially if you have the bad luck to get a UTI when everything is closed. Very happy that you continue to be cancer free, you are a true inspiration!

    ReplyDelete

Post a Comment

Popular posts from this blog

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...

38.6 months

September 18 marked 38.6 months (3 years, 2 months, 18 days) since I first started taking Tagrisso. Why is 38.6 months significant? Because it is the median overall survival in the FLAURA study, a landmark study (2014-16) comparing Tagrisso and older targeted therapies among patients with advanced non-small cell lung cancer, EGFR mutation, and no prior treatment. 279 patients received Tagrisso and 277 people received an older drug (in addition, all patients received at least one dose of a trial drug). Nearly 58% of patients had died when data collection stopped. However, patients in the Tagrisso group lived nearly 7 months longer (median) than the control group. When Leland and I initially read that number – 38.6 months – in the Tagrisso promotional materials, we were stunned. This was supposed to be good news? The median age in the FLAURA study was 64 and at the time (August 2022), I had just turned 50. But still, it was a sobering statistic. For the longest time, I didn't feel ...

A failure of institutional care

I just hit "send" on this letter to my dean and associate dean. Mic drop. I've never sent such a scathing letter, but it's definitely called for in this situation. I'm not expecting anything other than a "Oh, that wasn't how we intended to make you feel; our hands were tied" email. Dear Dean Lawless and Associate Dean Lloyd, When I wrote to Professor Land [my department head] to see if I could get a course release this fall due to having lung cancer plus complications from pulmonary embolism and COVID, I had no idea what I was in for. When faculty friends in other colleges have had health crises (ones that don’t warrant a full-semester medical leave), their department head or dean has simply said, “Don’t worry about teaching this semester. We’ll figure it out.” I figured the same would happen in my case. To be blunt, the way that my case was handled was a colossal failure of leadership. As my husband and I have shared my story with colleagues at PSU ...